Examination of opioid prescribing in Australia from 1992 to 2007

@article{Leong2009ExaminationOO,
  title={Examination of opioid prescribing in Australia from 1992 to 2007},
  author={Michael S. Leong and Bridin Patricia Murnion and Paul S Haber},
  journal={Internal Medicine Journal},
  year={2009},
  volume={39}
}
Background: Opioid prescribing is controversial with evidence of both significant under‐utilization and over‐utilization. There is some evidence to support efficacy for chronic non‐malignant pain, but community and individual harms are increasingly reported. 
The extent and correlates of community‐based pharmaceutical opioid utilisation in Australia
TLDR
Data is presented on opioid utilisation across Australia and sociodemographic factors that may affect utilisation rates are considered. Expand
Opioid analgesic prescribing in Australia: a focus on gender and age
TLDR
This work examined the gender and age trends in the prescribing of subsidised opioid analgesics in the Australian population for non‐palliative care indications and found that oxycodone and fentanyl use has increased substantially. Expand
Hospital discharge opioid guidelines and policies: a Victorian survey
Opioid prescribing has increased over the past two decades in Australia and has been associated with a rise in opioid‐related harm, including hospitalisations. Guidelines for supplying opioids atExpand
Changes in trends and pattern of strong opioid prescribing in primary care
This study evaluated the prescribing trends of four commonly prescribed strong opioids in primary care and explored utilization in non‐cancer and cancer users.
Prescribing databases can be used to monitor trends in opioid analgesic prescribing in Australia
TLDR
There has been increased use of prescription opioid analgesics in Australia in the past 20 years with increasing evidence of related problems, but little is known about the extent to which data sources agree on levels of opioid prescribing. Expand
Changes in opioid and other analgesic use 1995–2010: Repeated cross‐sectional analysis of dispensed prescribing for a large geographical population in Scotland
TLDR
This work identified and described changes in the pattern of community‐dispensed prescriptions to the Tayside population, Scotland, between 31st March 1995 and31st March 2010. Expand
Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013
TLDR
Recent trends in opioid prescribing and prescription opioid poisoning resulting in hospitalisation or death in Victoria, Australia are described. Expand
Safety of opioid patch initiation in Australian residential aged care
TLDR
To explore opioid use by aged care facility residents before and after initiation of transdermal opioid patches, a small number of residents received patches to treat anxiety and depression. Expand
Modifying emergency department electronic prescribing for outpatient opioid analgesia
The aim of this study was to examine how changing the electronic ordering sequences for opioid analgesics affected ED outpatient prescribing, and subsequent unused opioid tablets remaining in theExpand
Trends in opioid utilisation in Australia, 2006‐2015: Insights from multiple metrics
TLDR
This work combines volume‐based metrics with a measure of the number of persons dispensed opioids to gain insights into Australian trends in prescribed opioid use. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Australian trends in opioid prescribing for chronic non‐cancer pain, 1986‐1996
  • J. R. Bell
  • Medicine
  • The Medical journal of Australia
  • 1997
TLDR
To identify trends in the use of opioid drugs for chronic non‐cancer pain, a large number of the drugs used in this study are classified as either legal highs or misuse. Expand
Association between non-medical and prescriptive usage of opioids.
TLDR
The relationships between prescriptive usage of opioids and reported morbidity at the national level, using data from the Drug Abuse Warning Network, suggest that non-medical use of opioids is predictable based on potency and extent ofprescriptive use. Expand
Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects
TLDR
Weak and strong opioids outperformed placebo for pain and function in all types of CNCP and were significantly superior to naproxen and nortriptyline, and only for pain relief. Expand
The Epidemiologic Association Between Opioid Prescribing, Non-Medical Use, and Emergency Department Visits
TLDR
The increased number of prescriptions written for hydrocodone and oxycodone between 1995 and 2004 was associated with similar increases in non-medical use and the number of ED visits during this time period. Expand
Efficacy of Opioids for Chronic Pain: A Review of the Evidence
TLDR
It is concluded that existing evidence suggests that analgesic efficacy, although initially good, is not always sustained during continuous and long-term opioid therapy (months to years). Expand
Pain and addiction interface.
TLDR
This new section of Pain Medicine explores the point where pain, abuse, and addiction intersect, and the challenge is to ensure that adjustments to the clinical art and science of opioid prescribing are driven instead by rational empiricism so that the pendulum might be stopped in the middle. Expand
Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.
TLDR
Short-term studies provide only equivocal evidence regarding the efficacy of opioids in reducing the intensity of neuropathic pain, and further RCTs are needed to establish their long-term efficacy, safety, and effects on quality of life. Expand
Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000
TLDR
In spite of the increased attention to pain treatment, there has not been an increase in office visits for musculoskeletal pain complaints and the threshold for prescribing NSAIDS and opioids, however, has dropped. Expand
Ensuring opioid availability: methods and resources.
The pain and palliative care fields are encouraged to learn about government drug control policy and to engage with their governments to examine these policies and their implementation in order toExpand
Long-term Use of Controlled-release Oxycodone for Noncancer Pain: Results of a 3-year Registry Study
TLDR
These registry data demonstrate that a subgroup of patients with noncancer pain experienced prolonged relief with tolerable side effects and modest need for dose escalation during long-term therapy with CR oxycodone. Expand
...
1
2
3
...